Delivery Order SPE2DR25D1202-SPE2DR26F72ZE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Atovaquone-Proguanil 250-100 tablets in a quantity of 100 units, with a ceiling value of $1,343.16. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside transaction. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $15,817.44 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) on December 4, 2025, with completion scheduled for December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for malaria prophylaxis and...
- The Defense Logistics Agency awarded a delivery order valued at $3,804.24 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S, a antimalarial pharmaceutical product. The award, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, was made on a firm fixed-price basis without a set-aside designation, indicating competitive award through open competition. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,504.61 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count) with a contract ceiling value of $3,665.97. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The ultimate completion date is set for May 21, 2025, and performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,492.71 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) on November 4, 2025, with completion scheduled for November 5, 2025. This non-competitive delivery order utilizes firm fixed-price terms and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100-count units) with a ceiling value of $6,804.82. This is a firm fixed-price delivery order under a competitive, non-set-aside procurement. The order has an ultimate completion date of September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $6,156.15 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $9,457.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Atovaquone-Proguanil 250-100 100S, a antimalarial pharmaceutical product. The delivery order is non-set-aside and was competitively awarded, with an ultimate completion date of November 5, 2025. Performance of this contract will take place at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $8,058.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award was fulfilled from the company's place of performance in Conshohocken, Pennsylvania,...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72ZEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,900.61 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100s on December 11, 2025, with an ultimate completion date of December 12, 2025. This non-competitive delivery order is structured as a firm fixed price contract with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under a larger indefinite delivery contract vehicle. This delivery order falls under AmerisourceBergen's existing $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026. AmerisourceBergen serves as a prime vendor for pharmaceutical and medical supply distribution to support military healthcare programs globally. Atovaquone-Proguanil is an antimalarial medication commonly used for malaria prevention and treatment within military medical protocols. The firm fixed pricing structure and rapid completion timeline are typical for routine pharmaceutical replenishment orders under the broader DLA medical supply chain framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 12/10/25 |